1 – 10 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients : an European multicentre survey
(
- Contribution to journal › Article
- 2019
-
Mark
Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
(
- Contribution to journal › Article
-
Mark
The serotonergic system in L-DOPA-induced dyskinesia : pre-clinical evidence and clinical perspective
(
- Contribution to journal › Article
-
Mark
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2015
-
Mark
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
(
- Contribution to journal › Article
- 2013
-
Mark
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
(
- Contribution to journal › Article
- 2012
-
Mark
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment
(
- Contribution to journal › Article